A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

P Bossi, R Miceli, L D Locati, D Ferrari, S Vecchio, G Moretti, N Denaro, F Caponigro, C Moro, E Vaccher, A Sponghini, A Caldara, G Rinaldi, F Ferrau, F Nolè, S Lo Vullo, F Tettamanzi, L Hollander, L Licitra

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.

Medicine & Life Sciences